(NYSEMKT: XTNT) Xtant Medical Holdings's forecast annual revenue growth rate of -2.03% is not forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 7.82%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 13.72%.
Xtant Medical Holdings's revenue in 2026 is $121,907,000.On average, 4 Wall Street analysts forecast XTNT's revenue for 2026 to be $14,601,374,136, with the lowest XTNT revenue forecast at $14,022,789,426, and the highest XTNT revenue forecast at $15,037,591,942. On average, 5 Wall Street analysts forecast XTNT's revenue for 2027 to be $15,165,231,235, with the lowest XTNT revenue forecast at $14,295,600,883, and the highest XTNT revenue forecast at $16,039,069,476.
In 2027, XTNT is forecast to generate $16,076,940,475 in revenue, with the lowest revenue forecast at $15,442,951,896 and the highest revenue forecast at $16,553,834,539.